T
Tai Xiang Lu
Researcher at Sun Yat-sen University
Publications - 70
Citations - 3109
Tai Xiang Lu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Nasopharyngeal neoplasm & Nasopharyngeal carcinoma. The author has an hindex of 28, co-authored 68 publications receiving 2620 citations.
Papers
More filters
Journal ArticleDOI
Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy
Wei Wei Xiao,Shao Min Huang,Fei Han,S. Wu,Li Xia Lu,Cheng Guang Lin,Xiao Wu Deng,Tai Xiang Lu,Nian Ji Cui,Chong Zhao +9 more
TL;DR: The aim of this phase 2 study was to determine the long‐term local control, survival, and late toxicities among patients with locally advanced nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy (IMRT) with the simultaneous modulated accelerated radiation therapy (SMART) boost technique and concurrent chemotherapy.
Journal ArticleDOI
Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III Trials
Daniel T.T. Chua,Jun Ma,Jonathan S.T. Sham,Hai Qiang Mai,D. Choy,Ming Huang Hong,Tai Xiang Lu,Hua Qing Min +7 more
TL;DR: The addition of cisplatin-based induction chemotherapy to radiotherapy was associated with a modest but significant improvement in survival in advanced stage NPC.
Journal ArticleDOI
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W.M. Lee,Wai Tong Ng,Jianji Pan,Sharon Shuxian Poh,Yong Chan Ahn,Hussain AlHussain,June Corry,Cai Grau,Vincent Grégoire,Kevin J. Harrington,Chaosu Hu,Dora L.W. Kwong,Johannes A. Langendijk,Quynh-Thu Le,Nancy Y. Lee,Jin Ching Lin,Tai Xiang Lu,William M. Mendenhall,Brian O'Sullivan,Enis Ozyar,Lester J. Peters,David I. Rosenthal,Yoke Lim Soong,Yungan Tao,Sue S. Yom,Joseph Wee +25 more
TL;DR: A set of consensus guidelines has been developed to provide a practical reference for appropriate contouring to ensure optimal target coverage in nasopharyngeal carcinoma, based on optimal geometric expansion and anatomical editing for those structures with substantial risk of microscopic infiltration.
Journal ArticleDOI
Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy Alone
TL;DR: IMRT alone for Stage T1-T2bN0, T1N1, and T2N1 yielded satisfactory survival outcomes with acceptable toxicity, and no differences were found in survival outcomes among these four subgroups.
Journal ArticleDOI
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma
Anne W.M. Lee,Roger K.C. Ngan,Stewart Y. Tung,Ashley Cheng,Dora L.W. Kwong,Tai Xiang Lu,Anthony T.C. Chan,Lucy L.K. Chan,Harry Yiu,Wai Tong Ng,Frank Y. Wong,Kam Tong Yuen,Stephen Yau,FY Cheung,Oscar S.H. Chan,Horace C.W. Choi,Rick Chappell +16 more
TL;DR: The authors evaluated the potential therapeutic benefit from changing to an induction‐concurrent chemotherapy sequence, replacing fluorouracil with oral capecitabine, and/or using accelerated rather than conventional radiotherapy fractionation.